Detrimental effects of nicotine on thioacetamide-induced liver injury in mice

References

• Abbasi, M.H., et al., 2013. Acute and chronic toxicity of thioacteamide and alterations in blood cell indices in rats. Journal of cancer therapy, 4, 251–259.
   Google Scholar
• Albright, C.D., et al., 2003. Mitochondrial and microsomal derived reactive oxygen species mediate apoptosis induced by transforming growth factor‐β1 in immortalized rat hepatocytes. Journal of cellular biochemistry, 89, 254–261.
   PubMed Web of Science ®Google Scholar
• Altamirano, J. and Bataller, R., 2010. Cigarette smoking and chronic liver diseases. Gut, 59 (9), 1159–1162.
   PubMed Web of Science ®Google Scholar
• Azzalini, L., et al., 2010. Cigarette smoking exacerbates nonalcoholic fatty liver disease in obese rats. Hepatology, 51, 1567–1576.
   PubMed Web of Science ®Google Scholar
• Bataller, R., 2006. Time to ban smoking in patients with chronic liver diseases. Hepatology, 44, 1394–1396.
   PubMed Web of Science ®Google Scholar
• Bataller, R. and Brenner, D.A., 2005. Liver fibrosis. The journal of clinical investigation, 115, 209–218.
   PubMed Web of Science ®Google Scholar
• Baynes, J.W., 1991. Role of oxidative stress in development of complications in diabetes. Diabetes, 40, 405–412.
   PubMed Web of Science ®Google Scholar
• Belvisi, L., et al., 2005. Biological and molecular properties of a new alpha(v)beta(3)/alpha(v)beta(5) integrin antagonist. Molecular cancer therapeutics, 4, 1670–1680.
   PubMed Web of Science ®Google Scholar
• Bendeck, M.P., et al., 2000. Smooth muscle cell matrix metalloproteinase production is stimulated via alpha(v)beta(3) integrin. Arteriosclerosis thrombosis and vascular biology, 20, 1467–1472.
   PubMed Web of Science ®Google Scholar
• Benowitz, N., 2008. Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction. Clinical pharmacology & therapeutics, 83, 531–534.
   PubMed Web of Science ®Google Scholar
• Bhagwat, S.V., et al., 1998. Preferential effects of nicotine and 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone on mitochondrial glutathione S-transferase A4-4 induction and increased oxidative stress in the rat brain. Biochemical pharmacology, 56, 831–839.
   PubMed Web of Science ®Google Scholar
• Chen, I.S., et al., 2012. Hepatoprotection of silymarin against thioacetamide‐induced chronic liver fibrosis. Journal of the science of food and agriculture, 92, 1441–1447.
   PubMed Web of Science ®Google Scholar
• Chen, X., et al., 2016. Nicotine alleviates the liver inflammation of non-alcoholic steatohepatitis induced by high-fat and high-fructose in mice [Beijing da xue xue bao]. Journal of Peking University health sciences, 48, 777.
   Google Scholar
• Chilakapati, J., et al., 2007. Toxicokinetics and toxicity of thioacetamide sulfoxide: a metabolite of thioacetamide. Toxicology, 230, 105–116.
   PubMed Web of Science ®Google Scholar
• Desmet, V.J. and Roskams, T. 2004. Cirrhosis reversal: a duel between dogma and myth. Journal of hepatology, 40, 860–867.
   PubMed Web of Science ®Google Scholar
• Dongiovanni, P., et al., 2015. Statin use and non-alcoholic steatohepatitis in at risk individuals. Journal of hepatology, 63, 705–712.
   PubMed Web of Science ®Google Scholar
• Dooley, S., et al., 2003. Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats. Gastroenterology, 125, 178–191.
   PubMed Web of Science ®Google Scholar
• Fan, S. and Weng, C.-F., 2005. Co-administration of cyclosporine an alleviates thioacetamide-induced liver injury. World journal of gastroenterology: WJG, 11, 1411.
   PubMed Web of Science ®Google Scholar
• Gloire, G., Legrand-Poels, S., and Piette, J. 2006. NF-κB activation by reactive oxygen species: fifteen years later. Biochemical pharmacology, 72, 1493–1505.
   PubMed Web of Science ®Google Scholar
• Goette, A., et al., 2007. Cigarette smoking induces atrial fibrosis in humans via nicotine. Heart, 93, 1056–1063.
   PubMed Web of Science ®Google Scholar
• Gressner, A.M., et al., 2002. Roles of TGF-beta in hepatic fibrosis. Frontiers in bioscience, 7, d793–d807.
   PubMed Web of Science ®Google Scholar
• Herrera, B., et al., 2004. Source of early reactive oxygen species in the apoptosis induced by transforming growth factor-β in fetal rat hepatocytes. Free radical biology and medicine, 36, 16–26.
   PubMed Web of Science ®Google Scholar
• Hézode, C., et al., 2005. Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C. Hepatology, 42, 63–71.
   PubMed Web of Science ®Google Scholar
• Hong, F., et al., 2016. The role of CYP2A5 in liver injury and fibrosis: chemical-specific difference. Naunyn-Schmiedeberg's archives of pharmacology, 389, 33–43.
   PubMed Web of Science ®Google Scholar
• Jensen, K., et al. 2012. General mechanisms of nicotine-induced fibrogenesis. The FASEB journal, 26, 4778–4787.
   PubMed Web of Science ®Google Scholar
• Kim, J.W., et al., 2017. Evaluating the influence of side stream cigarette smoke at an early stage of non-alcoholic steatohepatitis progression in mice. Toxicological research, 33, 31–41.
   PubMedGoogle Scholar
• Kleiner, D.E., et al., 2005. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology, 41, 1313–1321.
   PubMed Web of Science ®Google Scholar
• Lakhan, S.E. and Kirchgessner, A., 2011. Anti-inflammatory effects of nicotine in obesity and ulcerative colitis. Journal of translational medicine, 9, 129.
   PubMed Web of Science ®Google Scholar
• Leask, A. and Abraham, D.J., 2004. TGF-beta signaling and the fibrotic response. The FASEB journal, 18, 816–827.
   PubMed Web of Science ®Google Scholar
• Lieber, C.S., 2002. S-Adenosyl-l-methionine: its role in the treatment of liver disorders. The American journal of clinical nutrition, 76, 1183S–1187S.
   PubMed Web of Science ®Google Scholar
• Liu, R.-M. and Pravia, K.G., 2010. Oxidative stress and glutathione in TGF-beta-mediated fibrogenesis. Free radical biology & medicine, 48, 1–15.
   PubMed Web of Science ®Google Scholar
• Parola, M. and Robino, G., 2001. Oxidative stress-related molecules and liver fibrosis. Journal of hepatology, 35, 297–306.
   PubMed Web of Science ®Google Scholar
• Patsenker, E., et al., 2009. Pharmacological inhibition of integrin αvβ3 aggravates experimental liver fibrosis and suppresses hepatic angiogenesis. Hepatology, 50, 1501–1511.
   PubMed Web of Science ®Google Scholar
• Pavlov, V.A. and Tracey, K.J., 2005. The cholinergic anti-inflammatory pathway. Brain, behavior, and immunity, 19, 493–499.
   PubMed Web of Science ®Google Scholar
• Pietrangelo, A., 1996. Metals, oxidative stress, and hepatic fibrogenesised. Seminars in liver disease, 16, 13–30.
   Google Scholar
• Seifried, H.E., et al., 2007. A review of the interaction among dietary antioxidants and reactive oxygen species. The journal of nutritional biochemistry, 18, 567–579.
   PubMed Web of Science ®Google Scholar
• Sekhon, H., et al., 2004. Prenatal nicotine exposure increases connective tissue expression in foetal monkey pulmonary vessels. European respiratory journal, 23, 906–915.
   PubMed Web of Science ®Google Scholar
• Soeda, J., et al., 2012. Nicotine induces fibrogenic changes in human liver via nicotinic acetylcholine receptors expressed on hepatic stellate cells. Biochemical and biophysical research communications, 417, 17–22.
   PubMed Web of Science ®Google Scholar
• Tang, L.-X., et al., 2012. Asiatic acid inhibits liver fibrosis by blocking TGF-beta/Smad signaling in vivo and in vitro. Plos one, 7, e31350.
   PubMed Web of Science ®Google Scholar
• Valavanidis, A., et al., 2006. Molecular biomarkers of oxidative stress in aquatic organisms in relation to toxic environmental pollutants. Ecotoxicology and environmental safety, 64, 178–189.
   PubMed Web of Science ®Google Scholar
• Verrecchia, F. and Mauviel, A., 2007. Transforming growth factor-beta and fibrosis. World journal of gastroenterology, 13, 3056–3062.
   PubMed Web of Science ®Google Scholar
• Wang, H., et al., 2003. Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation. Nature, 421, 384–388.
   PubMed Web of Science ®Google Scholar
• Williams, K., et al., 2012. Diabetes and nonalcoholic fatty liver disease: a pathogenic duo. Endocrine reviews, 34, 84–129.
   PubMed Web of Science ®Google Scholar
• Zein, C.O., et al., 2006. Smoking and increased severity of hepatic fibrosis in primary biliary cirrhosis: a cross validated retrospective assessment. Hepatology, 44, 1564–1571.
   PubMed Web of Science ®Google Scholar
• Zhang, K. and Kaufman, R.J., 2008. From endoplasmic-reticulum stress to the inflammatory response. Nature, 454, 455–462.
   PubMed Web of Science ®Google Scholar